Procure one pulsed field ablation (PFA) system, including generator, compatible catheters, required accessories/cables, training, warranty, and technical support.
Active Purchase Order Awarded Last action
- Contract number
- 75F40126P00408
- Awardee
-
Biosense Webster, Inc. UEI LU6KBGZ1A362 Part of Cardinal Health, Inc.
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $184,720
Award facts
- Opportunity
-
- Pulsed Field Ablation System (PFA) Solicitation · 75F40126Q00391 · Posted Aug 25, 2026
- Contract value 100% obligated
- $184,720.00 Current and potential, with all options
- Completion date 7% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Irvine, CA 92618, USA
Award details come from SAM.gov/FPDS.
About this award
The FDA awarded a purchase order to Biosense Webster, Inc. for one Pulsed Field Ablation system on September 28, 2026, with a ceiling value of $184,720.00.
The system, procured for the FDA's Center for Devices and Radiological Health at 10903 New Hampshire Avenue, Silver Spring, Maryland, comprises a PFA generator, five compatible clinical catheters, accessories, cables, software licenses, setup and startup assistance, functional testing, a manufacturer's standard twelve-month warranty, and technical support by telephone and email. Training must include at least one instructor-led session (in person or virtual) within fifteen business days of delivery covering system components, operation, safety, troubleshooting, and maintenance. The equipment must be FDA-approved or cleared for clinical use, new, unused, current production, and compatible with standard building power (115–120 volts, 60 hertz, single phase). Delivery is due within thirty calendar days of order receipt, FOB Destination. Performance of on-site activities is restricted to Monday–Friday, 6:30 a.m.–3:00 p.m. ET, excluding Federal holidays and facility closures. Ultimate completion date is November 19, 2027. The procurement originated from an FDA solicitation posted August 25, 2026, with offers due September 3, 2026, evaluated on Lowest Price Technically Acceptable basis.
Quick answers
Who was awarded contract 75F40126P00408?
75F40126P00408 was awarded to Biosense Webster, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 28, 2026.
How much is contract 75F40126P00408 worth?
The government has obligated $184,720 on 75F40126P00408.
Was contract 75F40126P00408 competed?
The extent of competition for 75F40126P00408 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award